{
    "clinical_study": {
        "@rank": "158009", 
        "acronym": "2013/004", 
        "arm_group": [
            {
                "arm_group_label": "PCA endovenous", 
                "arm_group_type": "Experimental", 
                "description": "1mg/10 min  Morphine"
            }, 
            {
                "arm_group_label": "PERIDURAL CATHETER", 
                "arm_group_type": "Active Comparator", 
                "description": "Peridural L-bupivacaine 0.25%"
            }, 
            {
                "arm_group_label": "TANSABDOMINAL BLOCK (TAP)", 
                "arm_group_type": "Active Comparator", 
                "description": "L-BUPIVACAINE im"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators would study the control of postoperative pain with peridural catheter,\n      morphine PCA ev or Transabdominal block."
        }, 
        "brief_title": "RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sigmoidal Tumour", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age more than 18\n\n          -  Laparoscopic sigmoidectomy\n\n          -  Informed consent firmed\n\n        Exclusion Criteria:\n\n          -  ASA IV\n\n          -  Urgent surgery\n\n          -  Sigmoid tumour stage IV\n\n          -  Cronic pain treatment\n\n          -  No informed consent firmed\n\n          -  Paliative surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "225", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01825993", 
            "org_study_id": "CIR TAP 2013", 
            "secondary_id": "2013-000556-17"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "PERIDURAL CATHETER", 
                    "TANSABDOMINAL BLOCK (TAP)"
                ], 
                "intervention_name": "L-BUPIVACAINE ; MORPHINE", 
                "intervention_type": "Drug", 
                "other_name": [
                    "PERIDURAL L-BUPIVACAINE", 
                    "PCA MORPHINE"
                ]
            }, 
            {
                "arm_group_label": "PCA endovenous", 
                "intervention_name": "MORPHINE", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Morphine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Peridural catheter", 
            "Morphine PCA", 
            "Transabdominal Block", 
            "laparoscopic sigmoidectomy"
        ], 
        "lastchanged_date": "April 5, 2013", 
        "location": [
            {
                "contact": {
                    "email": "Lmora@tauli.cat", 
                    "last_name": "Mora L Laura, MD", 
                    "phone": "34 937231010", 
                    "phone_ext": "24190"
                }, 
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "state": "Sabadell-Barcelona", 
                        "zip": "08208"
                    }, 
                    "name": "Corporacion Parc Tauli"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Lmora@tauli.cat", 
                    "last_name": "MORA L LAURA, MD", 
                    "phone": "34937231010", 
                    "phone_ext": "21490"
                }, 
                "contact_backup": {
                    "last_name": "mora"
                }, 
                "facility": {
                    "address": {
                        "city": "Sabadell", 
                        "country": "Spain", 
                        "state": "Sabadell-barcelona", 
                        "zip": "08208"
                    }, 
                    "name": "Corporacion Parc Tauli"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "3", 
        "official_title": "RANDOMISED STUDY ABOUT POTSOTERATORY PAIN CONTROL IN LAPAROSCOPIC SIGMOIDECTOMY", 
        "overall_contact": {
            "email": "Lmora@tauli.cat", 
            "last_name": "MORA L. LAURA, MD", 
            "phone": "34937231010", 
            "phone_ext": "21490"
        }, 
        "overall_official": {
            "affiliation": "Corporacion Parc Tauli", 
            "last_name": "PUJOL GEMMA, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Spain: Spanish Agency of Medicines"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators asked the patient the postoperative pain during teh first 72 hours by EVA scale.", 
            "measure": "EVA (POSTOPERATIVE PAIN)", 
            "safety_issue": "Yes", 
            "time_frame": "72 H POSTOPERATIVE"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825993"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Corporacion Parc Tauli", 
            "investigator_full_name": "LAURA MORA LOPEZ", 
            "investigator_title": "General Surgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "the investigators look for adverse effects", 
            "measure": "ADVERSE EFFECTS", 
            "safety_issue": "Yes", 
            "time_frame": "five days"
        }, 
        "source": "Corporacion Parc Tauli", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Corporacion Parc Tauli", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}